We help life sciences and healthcare companies optimize operations to drive efficiency, reduce costs, and improve overall performance across the value chain.

NDB Holding Group supports clients in streamlining manufacturing, supply chain, and commercial operations while navigating regulatory complexity, evolving technology, and global market demands. Our approach focuses on operational excellence, productivity improvement, and scalable solutions that deliver sustainable impact.

Our Operations Practice works with global and regional organizations across pharmaceuticals, biotech, medtech, and healthcare services. With a worldwide presence, we help clients benchmark performance, redesign processes, and implement technology-enabled solutions to improve efficiency and reduce operational risk.

We advise clients on end-to-end operations, from manufacturing and supply chain to commercial operations and service delivery. Many of our consultants have backgrounds in industrial engineering, supply chain management, and healthcare operations, providing deep expertise in process optimization, technology deployment, and performance improvement.

Our areas of expertise include:

• Manufacturing and supply chain optimization: Enhancing plant operations, production planning, logistics, and inventory management to reduce cost and improve throughput.

• Process redesign and operational excellence: Streamlining core processes, implementing lean and Six Sigma approaches, and embedding best practices across the organization.

• Technology-enabled operations: Deploying advanced analytics, digital tools, and automation to improve efficiency, decision-making, and real-time monitoring.

• Commercial and service operations: Improving order-to-cash, demand planning, and after-sales service to enhance customer satisfaction and operational performance.

• Regulatory compliance and risk management: Ensuring operations meet regulatory requirements while minimizing operational and quality risk.

Recent example of our work:
We supported a global biotech company in optimizing its manufacturing network by consolidating sites, redesigning workflows, and implementing predictive analytics in production planning. This resulted in a 20% increase in throughput, a 15% reduction in operational costs, and faster response times to market demand.